Access to medicines, March 30 -- In an open letter published today, Doctors Without Borders/Medecins Sans Frontieres (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Published by HT Digital Content Services with permission from NGO Daily News....